Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by Riverfolk


V.ARCH

Todays House Positions

House Positions for C:ARCH from 20210816 to 20210816...

August 16, 2021

V.ARCH

1% of the company has traded today around the high

House Positions for C:ARCH from 20210816 to 20210816...

August 16, 2021

V.ARCH

ACCUTE KIDNEY INJURY - $325 a share annual market unmet

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://archbiopartners...

August 15, 2021

V.ARCH

HUGE UPSIDE - 83% Efficacy in animal studies... Human data?

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://archbiopartners...

August 15, 2021

V.ARCH

Great Read !!

Thank you champ for posting, please find below the article posted along with...

August 15, 2021

V.ARCH

House Positions Today

House Positions for C:ARCH from 20210812 to 20210812 ...

August 12, 2021

V.ARCH

Arch - The calm before the storm

Todays price increase is a reminder to those who have held for some time...

August 12, 2021

V.ARCH

RE:RE:RE:52 week high!!!!

Currently, no specific therapies exist to prevent AKI in the world...

August 12, 2021

V.ARCH

RE:Short Term Catalyst (HUMAN DATA) Coming - My Due Diligence

For those of you new to the story, see below: Riverfolk wrote: Here is the...

August 12, 2021

V.ARCH

House Positions since recent upswing

House Positions for C:ARCH from 20210716 to 20210812...

August 12, 2021

V.ARCH

News - Human Trial Update

TORONTO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or...

August 5, 2021

V.ARCH

Current Price $1.38 - Awaiting Human Data

In my opinion there is zero premium built into this stock price, please find...

July 28, 2021

V.ARCH

Clinical Development Success Rates and Transition Durations

There is a reason that generational wealth can be created in this sector...

July 27, 2021

V.ARCH

Health Canada / FDA / Turkish Ministry of Health - Approvals

Metablok had completed Phase 1 when Covid 19 arrived, as shown below the...

July 25, 2021

V.ARCH

DPEP-1 Potential and Arch New Mechanism of Action

Currently, no specific therapies exist to prevent AKI in the world...

July 25, 2021

V.ARCH

Animal Data (Actual) vs Human Data(Expected)

Animal Data: A significant decrease in mortality was observed in DPEP1...

July 25, 2021

V.ARCH

Short Term Catalyst (HUMAN DATA) Coming - My Due Diligence

Here is the science published by a world renounced third party: Dipeptidase...

July 25, 2021

V.ARCH

RE:This is a gift

I agree with you 100%, this technology if safe in humans and proven to have...

July 16, 2021

V.ARCH

NEWS! CIHR Grant Metablok

TORONTO, July 14, 2021 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or...

July 14, 2021

V.ARCH

MetaBlok - originally invested to prevent organ inflammation

Metablok was originally invented to prevent organ inflammation related to...

June 15, 2021

Featured Company